NXEN — Nexien Biopharma Balance Sheet
0.000.00%
Last trade - 00:00- $0.69m
- $0.96m
Annual balance sheet for Nexien Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.011 | 0.018 | 0.117 | 0.035 | 0.004 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.023 | 0.026 | 0.125 | 0.043 | 0.004 |
| Total Assets | 0.023 | 0.026 | 0.125 | 0.043 | 0.004 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.029 | 0.039 | 0.242 | 0.295 | 0.365 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.029 | 0.039 | 0.242 | 0.295 | 0.365 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.006 | -0.014 | -0.118 | -0.252 | -0.361 |
| Total Liabilities & Shareholders' Equity | 0.023 | 0.026 | 0.125 | 0.043 | 0.004 |
| Total Common Shares Outstanding |